(E)-3-(1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylic acid, 100mg

fmoc-aib-oh, 98.0%, 1kg

Benzoic acid benzyl ester, min. 99%, for synthesis, 1 l, glass packaging

(R)-3-(2-(Benzyloxy)-5-bromophenyl)-N,N-diisopropyl-3-phenylpropan-1-amine, 97%, 250mg

(S)-1-Chloro-2-hydroxy-2-(p-fluorophenyl)ethane, 97%, 1g

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nepsilon-benzyloxycarbonyl-L-lysine>98.0%(HPLC)(T)25g

Sodium 2-carboxy-4-chlorobenzoate, 5g

(R)-4-(Iodomethyl)-2,2-dimethyl-1,3-dioxolane, 95.0%, 250mg

N-(4-Fluorophenethyl)-4-(4-methyl-7-oxo-2-(p-tolyl)-2H-pyrazolo[3,4-d]pyridazin-6(7H)-yl)butanamide, 98.0%, 250mg

2-Bromo-3-chloroaniline, 98.0%, 500g

Tetramethylsilane [for NMR]>99.0%(GC)500mL

Cyclopentanecarboxaldehyde (stabilized with HQ)>90.0%(GC)5mL

4-BROMOBICYCLO[2.2.2]OCTANE-1-CARBOXYLIC ACID, 95.0%, 5g